To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
March 8, 2006
Scott Armstrong, MD, PhD (Damon Runyon Clinical Investigator '03-'08) and Phillip Febbo, MD (Damon Runyon Clinical Investigator '05-'10) were featured in a recent article in Drug Discovery & Development, entitled "New Therapies Target Cancer."



